Oligodendrocyte Gene Therapy for Canavan Disease – Phase 1/2 Trial

Okay, here’s a breakdown of‍ the references you provided, formatted for clarity. ⁣I’ve extracted the key information from each entry.

Reference⁣ 29:

* Authors: Corti, M. et⁣ al.
* Title: Adeno-associated virus-mediated gene therapy ​in a patient ‌wiht Canavan disease using dual ⁢routes of administration adn immune modulation
* ⁣ Journal: Mol. Ther.‍ Methods Clin.Dev.

* Year: 2023
* Volume: 30
* Pages: 303-314
* DOI: 10.1016/j.omtm.2023.06.001
* Links:

* ⁣ Google Scholar

Reference 30:

* ⁢ Authors: Bley,​ A.⁤ et al.
*‌ Title: The natural history of Canavan‌ disease: 23 ‌new cases and ‍comparison with ‌patients from literature
* ⁣ Journal: Orphanet J. Rare Dis.

* Year: 2021
* Volume: ​ 16
*​ ‌ Pages: 227
* ​ DOI: 10.1186/s13023-020-01659-3
*‍ PubMed ID: 34011350
* PubMed Central Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132415

* Links:

​ ‌ * article

‍ * ⁢ PubMed

⁢ *⁣ ⁤ PubMed Central

​ *⁣ Google‍ Scholar

I hope this is helpful! Let me‍ know if⁤ you’d like me to do ​anything ⁢else ⁢with​ this information.